“Updated Integrated Safety Analysis of Ritlecitinib up to ~5 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s669. Accessed May 2, 2026. https://skin.dermsquared.com/skin/article/view/3867.